
Neulogy Ventures
Description
Neulogy Ventures is a Bratislava-based fund management company primarily focused on seed and venture capital investments within Slovakia and the broader Central European region. Established with a clear mission to support innovative technology companies possessing global potential, the firm plays a crucial role in the regional startup ecosystem. Neulogy Ventures manages funds that are robustly backed by significant institutional players, including the European Investment Fund (EIF), alongside various private investors, underscoring its credibility and financial capacity to support early-stage growth.
The firm operates through distinct investment vehicles tailored to different stages of company development. Its first significant fund, the Seed Fund, was launched in 2016 with a total commitment of EUR 15 million. This fund is specifically designed to target seed and Series A rounds, providing crucial early-stage capital. Typical initial investments from the Seed Fund range from EUR 100,000 to EUR 1.5 million, with the potential for follow-on investments extending up to EUR 3 million, allowing portfolio companies to secure further capital as they scale.
Building on the success of its initial fund, Neulogy Ventures introduced its Venture Capital Fund in 2019, which commands a total commitment of EUR 20 million. This larger fund is geared towards more mature early-stage companies, specifically targeting Series A and Series B rounds. The typical initial investment size from the Venture Capital Fund is considerably larger, ranging from EUR 500,000 to EUR 3 million. Furthermore, this fund has the capacity for substantial follow-on investments, potentially reaching up to EUR 5 million, which can be vital for companies pursuing significant expansion or market penetration.
Neulogy Ventures' strategic approach emphasizes identifying and nurturing technology companies that, despite their early stage, demonstrate strong potential for international growth and market disruption. By offering a tiered funding structure through its Seed and Venture Capital Funds, Neulogy Ventures provides a comprehensive financial pathway for startups from their nascent stages through significant growth phases. Its primary geographic focus on Slovakia and Central Europe highlights its commitment to fostering innovation within its home region, while still seeking companies with global ambitions.
Investor Profile
Neulogy Ventures has backed more than 47 startups, with 1 new investments in the last 12 months alone. The firm has led 5 rounds, about 11% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Convertible Note rounds (top funding stages).
- Majority of deals are located in Slovakia (Slovak Republic), United States, Austria.
- Strong thematic focus on Software, Information Technology, Artificial Intelligence (AI).
- Led 1 rounds in the past year.
- Typical check size: $108K – $3.2M.
Stage Focus
- Seed (47%)
- Series Unknown (26%)
- Convertible Note (13%)
- Pre Seed (11%)
- Series A (4%)
Country Focus
- Country not foundSlovakia (Slovak Republic) (64%)
- United States (28%)
- Austria (2%)
- Finland (2%)
- The Netherlands (2%)
- Germany (2%)
Industry Focus
- Software
- Information Technology
- Artificial Intelligence (Ai)
- Natural Language Processing
- Health Care
- Analytics
- Consulting
- Machine Learning
- Collaboration
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.